Trial Profile
Open Label, Non-randomised, Single Arm, Phase IIIB Switch Study: Evaluating the Clinical Benefits of Quetiapine XR in Patients With Schizophrenia and Anxiety Disorder.
Status:
Active, no longer recruiting
Phase of Trial:
Phase III
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Quetiapine (Primary)
- Indications Anxiety disorders; Schizophrenia
- Focus Therapeutic Use
- 29 Aug 2012 New trial record